AR055111A1 - Sal benzoato de 4-(5-metiloxazolo (4,5-metiloxazolo (4,5- b]piridin -2-il) -1,4- diabiciclo (3.2.2) nonano - Google Patents

Sal benzoato de 4-(5-metiloxazolo (4,5-metiloxazolo (4,5- b]piridin -2-il) -1,4- diabiciclo (3.2.2) nonano

Info

Publication number
AR055111A1
AR055111A1 ARP060103433A ARP060103433A AR055111A1 AR 055111 A1 AR055111 A1 AR 055111A1 AR P060103433 A ARP060103433 A AR P060103433A AR P060103433 A ARP060103433 A AR P060103433A AR 055111 A1 AR055111 A1 AR 055111A1
Authority
AR
Argentina
Prior art keywords
salt
benzoate salt
alzheimer
disease
metiloxazolo
Prior art date
Application number
ARP060103433A
Other languages
English (en)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of AR055111A1 publication Critical patent/AR055111A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente proporciona una sal benzoato de formula (1), la formula también es conocida como 4-(5-metiloxazolo[4,5-b]piridin-2-il)-1,4- diazabiciclo[3.2.2]nonano. La sal benzoato es util en el tratamiento de esquizofrenia y enfermedad de Alzheimer. Es particularmente util en el tratamiento de déficit cognitivos asociados a esquizofrenia, síntomas de déficit cognitivo y de atencion de la enfermedad de Alzheimer y neurodegeneracion asociada a la enfermedad de Alzheimer. Reivindicacion 2: La sal segun la reivindicacion 1, en la que la sal tiene picos de difraccion de rayos X en polvo característicos medidos con radiacion de cobre de 2-theta+-0,1° de 10,6, 12,9, 13,8,17,6 y 19,3.
ARP060103433A 2005-08-08 2006-08-07 Sal benzoato de 4-(5-metiloxazolo (4,5-metiloxazolo (4,5- b]piridin -2-il) -1,4- diabiciclo (3.2.2) nonano AR055111A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US70660105P 2005-08-08 2005-08-08

Publications (1)

Publication Number Publication Date
AR055111A1 true AR055111A1 (es) 2007-08-08

Family

ID=37398316

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060103433A AR055111A1 (es) 2005-08-08 2006-08-07 Sal benzoato de 4-(5-metiloxazolo (4,5-metiloxazolo (4,5- b]piridin -2-il) -1,4- diabiciclo (3.2.2) nonano

Country Status (6)

Country Link
AR (1) AR055111A1 (es)
DO (1) DOP2006000185A (es)
NL (1) NL1032286C2 (es)
TW (1) TW200738734A (es)
UY (1) UY29731A1 (es)
WO (1) WO2007017750A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009113950A1 (en) * 2008-03-10 2009-09-17 Astrazeneca Ab Therapeutic combinations of (a) an antipsychotic and (b) an alpha-4/beta-2 (a4b2)-neuronal nicotinic receptor agonist
EP2919788A4 (en) 2012-11-14 2016-05-25 Univ Johns Hopkins METHODS AND COMPOSITIONS FOR THE TREATMENT OF SCHIZOPHRENIA
KR102614709B1 (ko) 2016-12-20 2023-12-18 에르테에스 로만 테라피-시스테메 아게 아세나핀 및 폴리실록산 또는 폴리이소부틸렌을 함유하는 경피흡수 치료 시스템
CN110087640A (zh) 2016-12-20 2019-08-02 罗曼治疗系统股份公司 包含阿塞那平的透皮治疗系统
CN107188900B (zh) * 2017-05-27 2019-09-06 北京师范大学 α7烟碱型乙酰胆碱受体的配体化合物及其应用
US11033512B2 (en) 2017-06-26 2021-06-15 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system containing asenapine and silicone acrylic hybrid polymer
KR20210022656A (ko) 2018-06-20 2021-03-03 에르테에스 로만 테라피-시스테메 아게 아세나핀을 함유하는 경피 치료 시스템

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020086871A1 (en) * 2000-12-29 2002-07-04 O'neill Brian Thomas Pharmaceutical composition for the treatment of CNS and other disorders
CA2549638A1 (en) * 2003-12-23 2005-07-14 Pfizer Products Inc. Therapeutic combination for cognition enhancement and psychotic disorders

Also Published As

Publication number Publication date
DOP2006000185A (es) 2007-03-31
NL1032286C2 (nl) 2007-08-07
UY29731A1 (es) 2007-03-30
WO2007017750A1 (en) 2007-02-15
NL1032286A1 (nl) 2007-02-09
TW200738734A (en) 2007-10-16

Similar Documents

Publication Publication Date Title
AR055111A1 (es) Sal benzoato de 4-(5-metiloxazolo (4,5-metiloxazolo (4,5- b]piridin -2-il) -1,4- diabiciclo (3.2.2) nonano
NZ600430A (en) Spiro-oxindole mdm2 antagonists
MX2013001614A (es) Compuestos heterociclico.
TN2011000493A1 (en) 1-heterocyclyl -1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin -4- one derivatives and their use as pde9a modulators
MX2011008452A (es) Derivados de triazolo [4,3-b] piridazina y sus usos para el cancer de prostata.
GEP20166554B (en) Nitrogenated heterocyclic compound
TR201903981T4 (tr) Kanser tedavisi için bileşikler.
HK1143810A1 (en) Imidazo [1,2-a] pyrazine compounds for treatment of viral infections such as hepatitis
EP1954682A4 (en) NOVEL 2-AMINO-IMIDAZOLE-4-ONE COMPOUNDS AND THEIR USE IN THE MANUFACTURE OF A MEDICAMENT FOR USE IN THE TREATMENT OF COGNITIVE DEFICIENCY, ALZHEIMER'S DISEASE, NEURODEGENERATION AND DEMENTIA
CL2013000782A1 (es) Compuestos derivados de 4,7-dihidro-pirazolo (1,5-a) pirazin-6-ilamina, inhibidores de beta-secretasa (bace); composicion farmaceutica; y su uso en enfermedad de alzheimer, deterioro cognitivo lleve, senilidad, demencia, demencia asociada a derrame cerebral, parkinson o beta-amiloide.
IL235659A0 (en) History of 3, 4 - dihydro -2h - pyrido [1, 2 - a] pyrazine - 1,2,1] 6 converted diones used to treat (among others) Alzheimer's disease
WO2008134474A3 (en) Compositions and methods including cell death inducers and procaspase activation
ATE465163T1 (de) Heterocyclische verbindungen, ihre herstellung und ihre verwendung als antibakterielle mittel
ZA200610640B (en) Heteroaryl compounds for use as betamimetics in the treatment of respiratory diseases
CL2012000923A1 (es) Procedimiento para la preparacion de un polimero fotoprotector progresivo de organosilicio; polimero obtenido en forma de micro o nanoparticula; composicion cosmetica o dermatologica; monomero; procedimiento de preparacion del monomero; uso del polimero como precursor fotoquimico de absorbedores de uv como filtro solar.
TNSN07165A1 (en) Organic compounds
NZ627558A (en) Heterocyclic piperidine compounds and methods of their use
BR112014025702A2 (pt) compostos de tiofeno fotodinâmicos a base de metal e seus usos
NZ629914A (en) New derivatives of 5-aminolevulinic acid and their use as photosensitizing agents
BR112013017757A2 (pt) derivado de oxazina cristalino e seu uso como inibidor de bace
EA201101604A1 (ru) [1,2,4]триазоло[4,3-b]пиридазины в качестве лигандов андрогенового рецептора
ES1070114Y (es) Ropa de cama absorbente, impermeable y transpirable
EP2613849A4 (en) RADIOTHERAPY TO TREAT ALZHEIMER'S DISEASE
Díaz-Gallifa et al. Neutron diffraction studies on metal-organic magnetic solid solution. Searching for the tunable magnetic material
UA106368C2 (en) 1-heterocyclyl-1,5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their use as pde9a modulators

Legal Events

Date Code Title Description
FB Suspension of granting procedure